Your browser doesn't support javascript.
loading
Cutaneous manifestations of cystic fibrosis.
Smith, Aaron D; Schwartzman, Gabrielle; Lyons, Catherine E; Flowers, Hal; Albon, Dana; Greer, Kenneth; Lonabaugh, Kevin; Zlotoff, Barrett J.
Afiliação
  • Smith AD; University of Virginia School of Medicine, Charlottesville, Virginia. Electronic address: KDF2EB@virginia.edu.
  • Schwartzman G; Department of Dermatology, University of Virginia, Charlottesville, Virginia.
  • Lyons CE; University of Virginia School of Medicine, Charlottesville, Virginia.
  • Flowers H; Department of Dermatology, University of Virginia, Charlottesville, Virginia.
  • Albon D; Department of Pulmonology and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
  • Greer K; Department of Dermatology, University of Virginia, Charlottesville, Virginia.
  • Lonabaugh K; Department of Pulmonology and Critical Care Medicine, University of Virginia, Charlottesville, Virginia.
  • Zlotoff BJ; Department of Dermatology, University of Virginia, Charlottesville, Virginia.
J Am Acad Dermatol ; 91(3): 490-498, 2024 Sep.
Article em En | MEDLINE | ID: mdl-38697219
ABSTRACT
Cystic fibrosis (CF) is caused by a mutation in the Cystic fibrosis transmembrane conductance regulator (CFTR) gene, and features recurrent sinus and pulmonary infections, steatorrhea, and malnutrition. CF is associated with diverse cutaneous manifestations, including transient reactive papulotranslucent acrokeratoderma of the palms, nutrient deficiency dermatoses, and vasculitis. Rarely these are presenting symptoms of CF, prior to pulmonary or gastrointestinal sequelae. Cutaneous drug eruptions are also highly common in patients with CF (PwCF) given frequent antibiotic exposure. Finally, CFTR modulating therapy, which has revolutionized CF management, is associated with cutaneous side effects ranging from acute urticaria to toxic epidermal necrolysis. Recognition of dermatologic clinical manifestations of CF is important to appropriately care for PwCF. Dermatologists may play a significant role in the diagnosis and management of CF and associated skin complications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Regulador de Condutância Transmembrana em Fibrose Cística / Fibrose Cística Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article